Ticker: SBTX

Company: Silverback Therapeutics, Inc.

Person: Justin Chakma, officer

Transaction date: Nov. 12, 2025

Reporting date: Nov. 14, 2025

Average share price: 10.639004927408712

Sold 136380.0 shares for 1450947.49